Comparative analysis of the intracellular location of the high- and low-risk human papillomavirus oncoproteins

Virology

Volumn 293, Issue 1, 2002, Pages 20-25

  Guccione, Ernesto ^a   Massimi, Paola ^a   Bernat, Agnieszka ^a   Banks, Lawrence ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

E6; E7; HPV; Proteasome

Indexed keywords

ONCOPROTEIN; PROTEIN E6; PROTEIN E7; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HIGH RISK POPULATION; HUMAN; HUMAN CELL; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RISK ASSESSMENT; VIRUS TYPING;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRUS;

EID: 0036349075     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1290     Document Type: Article

References (26)

1. The E6 and E7 genes of HPV-18 are sufficient for inducing two stage in vitro transformation of human keratinocytes
2. Identification of human papillomavirus type 18 transforming genes in immortalised and primary cells
3. Induction of apoptosis in human papillomavirus-positive cancer cells by peptide aptamers targeting the viral E6 oncoprotein
4. Interaction of papillomavirus E6 oncoproteins with a putative calcium binding protein
5. Human pathogenic papillomavirus types: An update
6. Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4
7. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins
8. HSV-1 IE protein Vmw 110 causes redistribution of PML
9. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation
10. Interaction of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins
11. Human papillomavirus type 16 open reading frame E7 encodes a transforming gene for rat 3Y1 cells
12. Human papillomavirus type 16 E6 proteins with glycine substituted for cysteine in metal binding motifs
13. The human papillomavirus E6 protein and its contribution to malignant progression
14. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption
15. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein
16. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
17. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
18. Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16
19. Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130
20. Human papillomavirus type 16 E6 and E7 contribute differently to carcinogenesis
21. Nuclear dots: Actors on many stages
22. Human papillomavirus DNA replication compartments in a transient DNA replication system
23. Inhibition of Bak-induced apoptosis by HPV-18 E6
24. Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 anti-sense RNA
25. Association of human papillomavirus types 16 and 18 E6 proteins with p53
26. Human papillomaviruses in the pathogenesis of anogenital cancer